| Dr Joseph Blaise Girlando, DPM | |
|
7131 Liberty Rd, Suite 104, Baltimore, MD 21207-4575 | |
| (410) 944-8805 | |
| (410) 944-2370 |
| Full Name | Dr Joseph Blaise Girlando |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 7131 Liberty Rd, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316930035 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 00528 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph Blaise Girlando, DPM 7131 Liberty Rd, Suite 104, Baltimore, MD 21207-4575 Ph: (410) 944-8805 | Dr Joseph Blaise Girlando, DPM 7131 Liberty Rd, Suite 104, Baltimore, MD 21207-4575 Ph: (410) 944-8805 |
News Archive
Although alcohol consumption is known to be associated with chronic pancreatitis, new evidence indicates that a threshold of five or more drinks per day is required to significantly raise risk; however, most patients with chronic pancreatitis do not drink this amount, according to a report in the June 8 issue of Archives of Internal Medicine. In addition, smoking is an independent, dose-dependent risk factor.
The agreement resolves the two lawsuits brought by AHF against Abbott over the company's price increase for its HIV/AIDS drug, Norvir® (ritonavir).
A Mayo Clinic physician and two other pediatric experts say that parental perceptions pose a major barrier to acceptance of human papillomavirus (HPV) vaccination — and that many of those perceptions are wrong.
Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.
Scientists from MitoChroma Research have recently announced a patent-pending discovery that could complement current medical management modalities for Type 2 Diabetes, insulin resistance and the set of related conditions called "Metabolic Syndrome."
› Verified 3 days ago
Dr. Lewis Klotzman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5922 York Rd, Baltimore, MD 21212 Phone: 410-532-3070 Fax: 510-532-3101 | |
Sherman Podiatry, Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 1800 N Charles St Ste 208, Baltimore, MD 21201 Phone: 410-539-4282 Fax: 833-908-2252 | |
Richard I Chase, OWNER Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1721 Pennsylvania Ave, Baltimore, MD 21217 Phone: 410-523-2121 | |
Michael A. Doughty, D.p.m. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 404 Eastern Blvd Ofc 1, Baltimore, MD 21221 Phone: 410-687-4800 Fax: 410-687-3460 | |
Podiatry Associates, P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 404 Eastern Blvd Ste 1, Baltimore, MD 21221 Phone: 410-879-1212 | |
Albert I Ginsburg, D.P.M Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1050 North Point Road, Suite 200, Baltimore, MD 21224 Phone: 410-282-2234 Fax: 410-288-3843 | |
Dr. Sheldon Tajerstein, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 5411 Old Frederick Rd, Baltimore, MD 21229 Phone: 410-788-6633 |